Date published: 2025-11-7

00800 4573 8000

SCBT Portrait Logo
Seach Input

LTBP-2 Inhibidores

LTBP-2 inhibitors are a specialized class of compounds designed to target and inhibit the activity of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP-2). LTBP-2 is a member of the LTBP family of proteins that play a critical role in the regulation of transforming growth factor-beta (TGF-β) signaling, a key pathway involved in cellular growth, differentiation, and extracellular matrix (ECM) formation. Unlike other members of the LTBP family, LTBP-2 does not directly bind to TGF-β but instead interacts with the ECM and other structural components within the cellular environment. Inhibiting LTBP-2 offers researchers a unique tool to study its distinct role in ECM organization, the modulation of cell-matrix interactions, and its broader impact on cell signaling pathways.

The use of LTBP-2 inhibitors in scientific research is particularly valuable for exploring the non-TGF-β related functions of this protein, which are less understood compared to other LTBP family members. By inhibiting LTBP-2, researchers can disrupt its interactions within the ECM, allowing for a closer examination of how these interactions influence tissue architecture, cell adhesion, and mechanical signaling within various cellular contexts. Additionally, LTBP-2 inhibitors help to unravel the complexities of ECM dynamics, shedding light on how alterations in ECM composition and structure can affect cellular behavior and tissue integrity. This class of inhibitors is essential for advancing our understanding of ECM biology, providing insights into the intricate networks that maintain cellular and tissue homeostasis. Through the study of LTBP-2 inhibitors, researchers can gain a deeper appreciation of the multifaceted roles that ECM components play in regulating cell function and the overall maintenance of cellular environments.

VER TAMBIÉN ....

Nombre del productoNÚMERO DE CAS #Número de catálogoCantidadPrecioMENCIONESClasificación

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
¥903.00
¥2392.00
¥4603.00
48
(1)

Puede afectar indirectamente a la Proteína de Unión al Factor de Crecimiento Transformante Beta Latente (LTBP) al dirigirse a la vía del TGF-β.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
¥1185.00
¥1726.00
4
(1)

Otro inhibidor del TGF-β; también podría influir indirectamente en la proteína de unión al factor de crecimiento transformante beta latente (LTBP).

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
¥1862.00
¥2414.00
¥4468.00
¥6961.00
¥54199.00
19
(1)

Otro inhibidor de las MMP también podría influir indirectamente en la proteína de unión al factor de crecimiento transformante beta latente (LTBP).

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
¥745.00
¥2471.00
¥4705.00
97
(3)

Inhibidor de PI3K/Akt/mTOR; podría modular indirectamente la Proteína de Unión al Factor de Crecimiento Transformante Beta Latente (LTBP).

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
¥1365.00
¥4423.00
148
(1)

Otro inhibidor de PI3K/Akt/mTOR; también podría influir indirectamente en la Proteína de Unión al Factor de Crecimiento Transformante Beta Latente (LTBP).

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
¥699.00
¥1749.00
¥3610.00
233
(4)

Se dirige a mTOR, por lo que podría modular indirectamente la proteína de unión al factor de crecimiento transformante beta latente (LTBP).

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
¥699.00
¥1264.00
¥2414.00
¥3858.00
74
(2)

Otro inhibidor del EGFR; también podría afectar indirectamente a la proteína de unión al factor de crecimiento de transformación latente (LTBP).

Halofuginone

55837-20-2sc-507290
100 mg
¥19631.00
(0)

Inhibidor de Smad3; podría afectar indirectamente a la proteína de unión al factor de crecimiento de transformación latente (LTBP) a través de la señalización dependiente de Smad.